跳至主要内容
临床试验/NCT04251624
NCT04251624招募中不适用

A Randomized Control Trial Examining the Treatment Efficacy of a Novel Approach to Cognitive Remediation in Public Safety Personnel With Post-traumatic Stress Disorder (PTSD) and Co-morbid Conditions

Homewood Research Institute2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
88
试验地点
2
主要终点
Change in Score on the Return to Work Obstacles and Self-Efficacy Scale - Common Mental Disorders (ROSES-CMD)

研究概览

简要总结

This study examines the efficacy of Goal Management Therapy (GMT) - a well-established cognitive remediation strategy aimed at improving goal-directed behaviors that are dependent on basic cognitive processes and on executive functioning - among public safety personnel with post-traumatic stress disorder.

详细描述

Goal Management Therapy is a structured, short-term, CBT-based, cognitive remediation program with an emphasis on mindfulness, and practice in planning and completion of goal-oriented behaviours. The primary objective of GMT is to train participants to interrupt ongoing, disruptive behaviour through the resumption of executive control, in order to define goal hierarchies and monitor performance in achieving goals. Sessions include instructional material, interactive tasks, discussion of real-life deficits, and homework/practice activities.

The matched psychosocial education control group will focus on educating participants on topics like brain function and neuroplasticity, and on practicing lifestyle interventions (e.g., sleep hygiene, stress management, exercise).

The study will take place in three phases:

Phase 1 will consist of 6 sessions of Goal Management Therapy and 6 sessions of psychosocial education among public safety personnel and civilians who are inpatients at a mental health and addiction facility.

Phase 2 will consist of 9 sessions of Goal Management Therapy and 9 sessions of psychosocial education among public safety personnel who are members of the local community.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • have a diagnosis of post-traumatic stress disorder on the Clinician Administered PTSD Scale (CAPS)
  • are able to provide written informed consent

排除标准

  • receiving treatment with anti-cholinergics, anti-psychotic medication, or psychostimulants
  • use of benzodiazepines within the last 24 hours
  • have had Electroconvulsive therapy within the past year
  • a diagnosis of substance dependence or abuse within the past 6 months
  • a recent history (within the past 12 months) of medical disorder known to adversely affect cognition
  • a history of head trauma with more than one minute of loss of consciousness or a history of traumatic brain injury
  • a history of neurological disorder
  • a diagnosis of psychotic disorder or bipolar disorder
  • a history of a neurodevelopmental disorder

结局指标

主要结局

Change in Score on the Return to Work Obstacles and Self-Efficacy Scale - Common Mental Disorders (ROSES-CMD)

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A 46-item questionnaire that assesses readiness to return to work in individuals with common mental disorders on 10 possible dimensions: fears of a relapse, cognitive difficulties, medication-related difficulties, job demands, feeling of organization injustice, difficult relation-immediate supervisor, difficult relations-co-workers, difficult relations-insurance company, difficult work/life balance, and loss of motivation to return to work. Items use a 7-point response scale and include specific questions to assess perceived obstacles (1=not an obstacle, 7=Big obstacle) and self-efficacy beliefs about overcoming the obstacles (1=not at all capable, 7=completely capable). Higher scores on 'obstacles' items and lower scores on 'self-efficacy' items indicate decreased readiness to return-to-work.

Change from baseline in scores on the PTSD Checklist for DSM-5 (PCL-5) at post-intervention

时间窗: Phase 2 (outpatient): Baseline, week 3 of intervention, week 6 of intervention, post-intervention at 9 weeks, 3 months post-intervention, and 6 months post-intervention

A 20-item self-report measure that assesses the severity of PTSD symptoms according to the diagnostic criteria outlined in the DSM-5. Symptom domains are intrusions, avoidance, negative alterations in mood and cognitions, and alterations in arousal and reactivity.

Change in Score on the Delis-Kaplan Executive Function System (D-KEFS) Tower Test

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological assessment of planning, rule learning, response inhibition, and perseveration. Six scores are calculated: i) Total Achievement Score, which is the sum of achievement scores for all items administered. ii) Mean First-Move Time which reflects the average of the examinee's first move times. iii) Time-Per-Move Ratio, which indicates the average time the examinee takes to make each of his or her moves. iv) Move Accuracy Ratio is a means of assessing the efficiency with which the examinee constructed the towers. v) Total Rule Violations represents the total number of rule violations committed by the examinee across all items administered. vi) Rule-Violations-Per Item Ratio, reflects the average number of rule violations made by the examinee relative to the number of items administered. The total number of rule violations across all items administered is divided by the number of items administered. Higher scores indicate greater executive functioning performance.

Change in Score on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

时间窗: Phase 1 (inpatient): Baseline, post-intervention at 3 weeks, and post-intervention at 3 months

The WHODAS 2.0 is a 12-item self-report measure of six functional domains, including cognition, mobility, self-care, getting along with others, life activities, and participation in the community. The WHODAS 2.0 uses a Likert scale ranging from 0 ("No difficulty") to 4 ("Extreme difficulty or cannot do"). Values across the 12 items are summed, with the total score ranging between 0 and 48. Higher values indicate greater functional impairment.

Change in Score on the Stroop Colour and Word Test (SCWT)

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological test where individuals read colour words or names ink colors from different pages as quickly as possible within a time limit. It provides indices of processing speed and areas of executive functioning, such as cognitive flexibility, resistance to interference, and response inhibition. The test includes three stimulus sheets that yield three raw scores that are the number of words or ink colors read within the time limit (min = 0; no max score). Raw scores are converted to T scores using manualized procedures. Higher T scores indicate better performance.

Change from Baseline in Score on the Cognitive Failures Questionnaire (CFQ) at 3 weeks post-intervention and 3 months post-intervention

时间窗: Phase 1 (inpatient): Baseline, post-intervention at 3 weeks, and post-intervention at 3 months. This measure will also be administered during week 1, week 3, week 6, and week 9 of the intervention.

The CFQ is a 25-item self-report measure that captures daily errors in distractibility, blunders, names, and memory. Each item is rated on a Likert scale from 0 ("Never") to 4 ("Very often"). The CFQ has four subscales that include: i) Memory (i.e., sum of scores on items 16, 18, 12, 17, 23, 13, 6, 3 for a total score between 0 and 32); ii) Distractibility (i.e., sum of scores on items 1, 15, 2, 19, 21, 22, 3, 4, 25 for a total score between 0 and 36); iii) Blunders (i.e., sum of scores on items 9, 8, 10, 24, 5, 14, 11 for a total score between 0 and 28); and iv) Names (i.e., sum of scores on items 20 and 7 for a total score between 0 and 8). The CFQ total score is the sum of the 25 items, with total values ranging between 0 and 100. Higher scores indicate greater self-reported impairment in cognitive functioning.

Advanced Clinical Solutions Test of Premorbid Functioning (TOPF)

时间窗: Phase 1 (inpatient): Baseline only

The TOPF is a word-reading neuropsychological test that estimates an individual's level of cognitive and memory functioning before the onset of injury or illness. The test yields one raw score (total number of words correctly read before the discontinue criteria was met) that is converted to a T score. Higher T scores indicate better performance.

Change from baseline in symptom severity as assessed by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at post-intervention

时间窗: Phase 3 (fMRI): Baseline and post-intervention at 9 weeks

A 30-item structured, clinician-administered interview used to make a lifetime or current diagnosis of PTSD and to assess PTSD symptoms. Questions target the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning, improvement in symptoms on social and occupational functioning, and specifications for the dissociative subtype.

Change from baseline in score on the Sustained Attention Response Task (SART) adapted for functional Magnetic Resonance Imaging (fMRI) at post-intervention

时间窗: Phase 3 (fMRI): Baseline and post-intervention at 9 weeks

A computer-based 'Go/No-Go' task adapted for fMRI that requires participants to inhibit a behavioural response to a single, infrequent target appearing amidst a presentation of frequent non-targets. Participants will be asked to press a button for every number presented except "3", under two conditions: 1. a randomized presentation of numbers in two sets, each lasting one minute, and, 2. a sequential presentation of numbers. Each condition will be presented three times. The second presentation of the numbers will be preceded by certain specific emotion-evoking 'trauma words' identified by the participant at a prior appointment.

Change in Score on the Wechsler Adult Intelligence Scale-IV (WAIS-IV) Coding subtest

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological assessment of processing speed. In a time limit of 120 seconds, the participant copies symbols that are paired with numbers based on a symbol key. The total raw score is calculated by scoring 1 point for each correctly drawn symbol completed within the time limit. Raw scores range between 0 and 135 points. The raw score is converted to a scaled score corrected for age and the scaled score may range between 1 and 19. Higher scaled scores indicate greater processing speed than lower scaled scores.

Change in Score on Conners Continuous Performance Task Third Edition (CPT-3)

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological assessment of inattentiveness, impulsivity, sustained attention, and vigilance. Values include: i) D-prime-discrimination of non targets from targets; ii) Omissions- all missed targets; iii) Commissions- all incorrect responses to non-targets; iv) Perseverations- response in less than 100 milliseconds following the presentation of a stimulus; v) Hit Reaction Time- mean response speed measured in milliseconds for all non-perseverative responses made during the entire administration; vi) Hit Reaction Time SD-consistency of response speed to targets for the entire administration; vii) Variability- response speed consistency; viii) Hit Reaction Time Block Change- slope of change in Hit Reaction Time across the six blocks of the administration; and ix) Hit Reaction Time Inter-Stimulus Interval Change slope of change in reaction time across the three inter-stimulus intervals. All scores are presented in T scores with higher T scores indicating worse performance.

Change from baseline in scores on the Sustained Attention Response Task (SART)

时间窗: Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention

Assesses sustained attention by requiring participants to withhold behavioural response to a single, infrequent target presented among a background of frequent non-targets; administered using Inquisit Web by Millisecond (software for administering neuropsychological testing online).

Change from Baseline in Score on the VOT Hooper Visual Organization Test at 3 weeks post-intervention

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological assessment of visual integration, the VOT requires individuals to identify common object that have been fragmented by mentally rearranging fragments of the object presented on a card, with a total of 30 cards. The VOT is scored by hand to obtain a single raw score, which is then corrected based on age and level of education. The corrected raw score is used to derive a T score, which is the value of interest. Higher T scores reflect better performance.

Change in Score on the Rey-Osterrieth Complex Figure Test (RCFT)

时间窗: Phase 1 (inpatient): Baseline and post-intervention at 3 weeks

A neuropsychological test in which participants are required to copy a complex drawing to provide insight into individuals visuospatial/visuoconstructive abilities and areas of executive functioning (e.g., planning, organization). A single raw score is computed by hand using a manualized procedure which is then converted to a T score. This computed T score is the value of interest for this study, with higher T scores reflecting better performance.

Change in Score on the Depression Anxiety Stress Scale (DASS-21)

时间窗: Phase 1 (Inpatient): Week 1, Week 3, and Week 6 of intervention, and post-intervention at 3 weeks

The DASS-21 is a self-report measure that assesses the presence and severity of symptoms of depression, anxiety, and stress over the last week. Respondents rate their symptoms on a 4-point scale with 0 representing absence of the symptom and 3 representing a symptom occurring almost all the time. Three scores are computed, one for each subscale (depression, anxiety, and stress), by summing all the values of the items on each respective subscale. The total scores for each subscale are then multiplied by 2. Higher scores reflect greater symptom severity and the calculated scores can be used to qualify the severity of the symptoms (e.g., normal/minimal, mild, moderate, severe, extremely severe).

Change from baseline in scores on the Depression and Anxiety Stress Scale (DASS-21) at post-intervention

时间窗: Phase 2 (outpatient): Baseline, week 3 of intervention, week 6 of intervention, post-intervention at 9 weeks, 3 months post-intervention, and 6 months post-intervention

A self-report measure that assesses the presence and severity of symptoms of depression, anxiety, and stress over the last week. Respondents rate their symptoms on a 4-point scale with 0 representing absence of the symptom and 3 representing a symptom occurring almost all the time. Three scores are computed, one for each subscale (depression, anxiety, and stress), by summing all the values of the items on each respective subscale.

Change from baseline in scores on the Cognitive Failures Questionnaire (CFQ) at post-intervention

时间窗: Phase 2 (outpatient): Baseline, week 3 of intervention, week 6 of intervention, post-intervention at 9 weeks, 3 months post-intervention, and 6 months post-intervention

A 25-item measure of self-reported cognitive impairment that captures daily errors in distractibility, blunders, names, and memory. Each item is rated on a Likert scale from 0 ("Never") to 4 ("Very often").

Functional neurological change from baseline at post-intervention

时间窗: Phase 3 (fMRI): Baseline and post-intervention at 9 weeks

Functional Magnetic Resonance Imaging (fMRI) scans done at baseline and post-intervention will be compared to determine whether changes are apparent, post-intervention, in the functional organisation of the Central Executive Network (CEN)

次要结局

  • Change from baseline in scores on Digit Symbol Substitution Task at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Demographic Information(Phase 3 (fMRI): Collected at baseline only)
  • Change in accuracy of episodic memory recall as measured using a standard EEG(Phase 1 (inpatient): baseline, post-intervention at 3 weeks.)
  • Change from baseline in scores on the World Health Organization's Disability Assessment Schedule (WHODAS 2.0) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Mini International Neuropsychiatric Interview 7.0 (M.I.N.I.)(Phase 1 (inpatient): administered at baseline only)
  • Change in score on the PTSD Checklist for DSM-5 (PCL-5)(Phase 1 (inpatient): administered at 3 months post-intervention. This measure will also be administered during week 1, week 3, week 6, and week 9 of the intervention.)
  • Change in Score on the Multiscale Dissociation Inventory (MDI)(Phase 1 (inpatient): administered during week 1, week 3, week 6, and week 9 of the intervention and at 3 months post-intervention)
  • Change from baseline in scores on the Difficulties in Emotion Regulation Scale (DERS) at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on the Rey Complex Figure Task (RCFT) at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on the Return to work Obstacles and Coping Efficacy - Common Mental Disorders (ROSES-CMD) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in scores on the Lam Employment Absence and Productivity Scale (LEAPS) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in scores on the Sheehan Disability Scale (SDS) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Scores on the Moral Injury Events Scale (MIES) at baseline(Phase 2 (outpatient): Administered at baseline only)
  • Scores on the Advanced Clinical Solutions (ACS) Test of Premorbid Functioning (TOPF) at baseline(Phase 3 (fMRI): Administered at baseline only)
  • Change from baseline in scores on the Multiscale Dissociation Inventory (MDI) at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on the Toronto Alexithymia Scale (TAS) at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on the Hopkins Verbal Learning Test-Revised (HVLT-R) at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on the BADS Dysexecutive Questionnaire (DEX) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Scores on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at baseline(Phase 2 (outpatient): Administered at baseline only)
  • Scores on the Childhood Trauma Questionnaire (CTQ) at baseline(Phase 3 (fMRI): Administered at baseline only)
  • Change from baseline in scores on the Coding subtest of the Wechsler Adult Intelligence Scale-IV (WAIS-IV) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in scores on California Verbal Learning Test (CVLT-3) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in scores on the Symbol Search subtest of the Wechsler Adult Intelligence Scale-IV (WAIS-IV) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in score on the Depression and Anxiety Stress Scale (DASS-21) at post-intervention(Phase 3 (fMRI): Baseline, week 3 of intervention, week 6 of intervention, and post-intervention at 9 weeks)
  • Change from baseline in score on the Multiscale Dissociation Inventory (MDI) at post-intervention(Phase 3 (fMRI): Baseline, week 3 of intervention, week 6 of intervention, and post-intervention at 9 weeks)
  • Change from baseline in score on the Difficulties in Emotion Regulation Scale (DERS) at post-intervention(Phase 3 (fMRI): Baseline, week 3 of intervention, week 6 of intervention, and post-intervention at 9 weeks)
  • Scores on the Life Events Checklist for DSM-5 (LEC-5) at baseline(Phase 3 (fMRI): Administered at baseline only)
  • Scores on the Mini International Neuropsychiatric Interview (M.I.N.I.) 7.0 at baseline(Phase 2 (outpatient): Administered at baseline only)
  • Change from baseline in scores on the Digit Span subtest of the Wechsler Adult Intelligence Scale-IV (WAIS-IV) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in score on the Toronto Alexithymia Scale (TAS) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in score on the PTSD Checklist for DSM-5 (PCL-5) at post-intervention(Phase 3 (fMRI): Baseline, week 3 of intervention, week 6 of intervention, and post-intervention at 9 weeks)
  • Change from baseline in score on the Moral Injury Assessment for Public Safety Personnel (MIA-PSP) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Change from baseline in scores on the Cognitive Failures Questionnaire (CFQ) at post-intervention(Phase 3 (fMRI): Baseline, week 3 of intervention, week 6 of intervention, and post-intervention at 9 weeks)
  • Change from baseline in scores on the Survey of Perceived Organizational Support (SPOS) at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)
  • Scores on the Mini International Neuropsychiatric Interview 7.0.2 (M.I.N.I.) at baseline(Phase 3 (fMRI): Administered at baseline only)
  • Change from baseline in scores on selected subtests of the CBS Research battery at post-intervention(Phase 2 (outpatient): Baseline, post-intervention at 9 weeks, 3 months post-intervention, 6 months post-intervention)
  • Change from baseline in scores on selected subtests of the Creyos battery at post-intervention(Phase 3 (fMRI): Baseline and post-intervention at 9 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Investigating the Use of Goal Management Therapy in... | 临床试验